9 results
diabetes endocrinology summary agonists dosing dpp4 management medications sglt2 allopurinol classification comparison dmii gout hypoglycemics inpatient mellitus oral pathophysiology receptor
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... normally inactivates GLP ... failure Common Side ... #Pharmacology # ... Summary #DM2 #diabetes
Oral Hypoglycemics in Diabetes Management 1 INSULIN SENSITIZER • TZD -
CARB ABSORPTION INHIBITOR ... INCRETIN AGENTS • GLP ... - Prevents GLP ... Diabetes #Management #pharmacology ... #DM2 #DMII #Classification
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... the pancreas (GLP ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
GLP-1 Agonists ... However, GLP-1's ... Common side effects ... #Pharmacology #Dosing ... #Diabetes #DM2
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... of use) Common Side ... #Pharmacology # ... Summary #DM2 #diabetes
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... Increase Incretins (GLP-I ... with only few side ... Renal #Dosing #Pharmacology ... Management #Diabetes #DM2
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... drugs include side ... #Pharmacology # ... Medications #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP-4 inhibitor ... , GLP-1 receptor ... α-glucosidase inhibitor ... Diabetes #Mellitus #DM2 ... #Medications #pharmacology
Allopurinol Pharmacology Summary Xanthine oxidase inhibitor blocking the formation of new uric acid Initiate 1-2 days prior to
Allopurinol Pharmacology ... Xanthine oxidase inhibitor ... Dosing: 100 mg/m2 ... CrCl <10mL/min Side ... #Allopurinol #Pharmacology
No results found for "Wide pocus pharmacology pulmonaryembolism dm2 inhibitors glp1"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Wide #pocus #pharmacology #pulmonaryembolism #dm2 #inhibitors #glp1